This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Accelerate oligonucleotide and peptide products from early discovery to late-stage development & commercialization.

Oligonucleotide scale-up and the impact of equipment with Asahi Kasei Bioprocess America

Share this article

Liam Takahashi, Product Engineer at Asahi Kasei Bioprocess America (AKBA), explains how specifications of equipment such as synthesis columns benefit oligo development and scale-up processes.

He was interviewed by Michael Dunnet for TIDES TV.

Watch the full interview above or here.

Share this article

Upcoming event

TIDES Asia: Oligonucleotide & Peptide Therapeutics Scientific Forum

14 - 16 Sep 2022, Kyoto, Japan
Industry leaders and service providers share cutting-edge content and company expertise across the Oligonucleotide, Peptide, mRNA and Drug Delivery spectrum
Go to site